Metraipolis › archive › dc_440938d030a2
Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities — Europe PMC PMID:42093646
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42093646
- DOI
- 10.1042/bst20250097
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T23:31:09.596Z
- SHA-256 of the archived text
6f12ebd650006d70c82041546f4e500647f56eb5a558e105a1f53ebc08909133- Stable URL of this page
https://metraipolis.com/documento/dc_440938d030a2
How to cite
Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities — Europe PMC PMID:42093646 — Europe PMC (en), https://europepmc.org/article/MED/42093646 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_440938d030a2 (Metraipolis archive dc_440938d030a2, sha256 6f12ebd650006d70c82041546f4e500647f56eb5a558e105a1f53ebc08909133)
BibTeX
@misc{dc440938d030a2,
title = {Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities — Europe PMC PMID:42093646},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42093646},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_440938d030a2; sha256 6f12ebd650006d70c82041546f4e500647f56eb5a558e105a1f53ebc08909133},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42093646. Agents can read the archived copy with the MCP tool read_document.